About the Research Program
The Mood Disorders Research Program at Ben Taub is dedicated to testing novel treatments for schizophrenia, depression, Bipolar Disorder, and other various neuropsychiatric disorders. The program has a focus on psychopharmacology through many Phase 2, Phase 3 and Phase 4 pharmaceutical drug trials. Other collaborative research studies in this program use a variety of creative research techniques such as survey data collection, neuroimaging, and neurocognitive biological marker assessments. Goals of the program include developing improved treatment techniques and educational research enrichment in the behavioral medicine field.
About Our Research Studies
The Mood Disorder Research Program has a focus on psychotic disorders, tardive dyskinesia, schizophrenia, depression, bipolar disorder, suicidality, and psychopharmacology. Many of our studies are testing new clinical drugs that may improve the quality of life for you or your loved ones if other treatment options are not as effective as you would like. Our other research studies may also provide valuable information on prevention or treatment plans that are not widely used or studied. Your participation in our research studies will greatly contribute to the behavioral medicine field. Our team always tries our best to accommodate potential patients because we value your time. All of our studies provide compensation for your time and travel.
Please note the following requirements to participate in our research clinical trials:
- A diagnosis of Major Depressive Disorder (MDD), schizophrenia, bipolar and personality disorder
- Age between 18 and 65 years old
- No current alcohol or substance abuse
- No unstable medical or neurological illnesses
- Willingness to obtain copies of medical records from treating and previous providers if necessary
Our contact numbers are (346) 266- 8167 and (713) 873-5145.